News on Merck

US pharma giant Merck backs healthcare marketplace HD in Southeast Asia

China leaves Merck in need of a new profit injection

Stocks making the biggest moves premarket: Pfizer, PepsiCo, Palantir, Merck and more

Merck shares plunge as company pauses Gardasil vaccine shipments in China, hurting 2025 outlook

Merck Halts China Gardasil Shipments, Boosting Investor Concern

Merck sales forecast underwhelms as it pauses some shipments in China

RFK Jr. plans to keep a financial stake in lawsuits against the drugmaker Merck

China's WuXi Biologics to sell Irish vaccine facility to Merck as US curbs loom

Merck to develop weight loss pill from Chinese drugmaker in up to $2 billion licensing deal

Merck says Keytruda injection on par with approved IV version in trial

Merck tops earnings estimates on strong demand for Keytruda, new drugs even as HPV vaccine sales fall

Merck says experimental RSV treatment protected infants in trial, paving way for potential approval

Stocks making the biggest premarket moves: Boeing, Dell, Merck and more

Merck Buying Drug Targeting B-Cell Diseases for Up to $1.3 Billion

Merck shares fall 9% despite earnings beat, strong demand for top drugs like Keytruda

Stocks making the biggest moves premarket: CrowdStrike, Merck, PayPal, JetBlue and more

Merck is betting on AI partnerships to develop new drugs, but refraining from bringing in external expertise through acquisitions.

Germany's Merck Bets on AI Drug-Design Pacts, Rules Out M&A

Moderna, Merck say vaccine improved survival in patients with deadly skin cancer

Ozempic supply trackers, bird flu vaccines, and Merck's future: Pharma news roundup

Healthy Returns: Pfizer, Merck, J&J and more to release cancer drug data at industry conference

Merck is spending $3 billion on an eye drug developer as it braces to lose a key cancer patent

Merck Reaches $1.3 Billion Deal for Eye-Drug Company EyeBio